The current findings suggest that CD90low glioma-associated mesenchymal stromal/stem cells promote chemotherapeutic resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells. Here, FOXS1 is linked to central nervous system cancer.